Episode 1 (October 17, 2024): In the premiere episode of Behind the Breakthroughs, Geoff Oxnard, MD, VP of Clinical Development at Lilly and a Thoracic Oncologist at Boston Medical Center, shares his journey in precision medicine, beginning with his introduction to genetic testing as a Medical Oncology Fellow at Memorial Sloan-Kettering Cancer Center and as an academic researcher.

Dr. Oxnard discusses how differences in impact and reach influenced his decision to move from academia to industry. He also explains how the adoption of precision testing in the United States is influenced by perspective rather than accessibility. This episode also covers flexible enrollment in clinical trials, adapting to patient perspectives on clinical research as care, the current state of precision medicine, particularly precision oncology, in the United States and elsewhere, and more.

You can find the transcription of the interview’s highlights here.

Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter here.

Produced by Inside Precision Medicine, Publisher, Bill Levine

Music provided by Artem Hramushkin

Audio mixed and mastered by Jason Mack

Hosted on Acast. See acast.com/privacy for more information.